Assessment of liquid microbead arrays for the screening of newborns for spinal muscular atrophy

Clinical Chemistry

Volumn 53, Issue 11, 2007, Pages 1879-1885

  Pyatt, Robert E ^a   Mihal, David C ^a   Prior, Thomas W ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA EXTRACTION; EXON; GENE DELETION; HOMOZYGOTE; HUMAN; LABORATORY TEST; LIQUID MICROBEAD ARRAY; MICROARRAY ANALYSIS; NEWBORN; NEWBORN SCREENING; SENSITIVITY AND SPECIFICITY; SMN1 GENE; SPINAL MUSCULAR ATROPHY; VALIDATION PROCESS;

CLUSTER ANALYSIS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DNA; GENE DELETION; GENE DOSAGE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; INFANT, NEWBORN; MICROSPHERES; NEONATAL SCREENING; NERVE TISSUE PROTEINS; RNA-BINDING PROTEINS; SENSITIVITY AND SPECIFICITY; SPINAL MUSCULAR ATROPHIES OF CHILDHOOD;

EID: 35648932393     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.092312     Document Type: Article

References (24)

1. Tarini BA, Christakis DA, Welch GW. State newborn screening in the tandem mass spectrometry era: more tests, more false-positive results. Pediatrics 2007;118:448-56.
2. American College of Medical Genetics, American Society of Human Genetics, Test and Technology Transfer Committee Working Group. Tandem mass spectrometry in newborn screening. Genet Med 2000;2:267-9.
3. Howell RR. The high price of false positives. Mol Genet Metab 2006;87:180-3.
4. Pearn J. Genetic studies of acute infantile spinal muscular atrophy (SMA type I): an analysis of sex ratios, segregation ratios, and sex influence. J Med Genet 1978;15:414-7.
5. Dubowitz V. Chaos in the classification of SMA: a possible resolution. Neuromuscul Disord 1995;5:3-5.
6. Lorson CL, Hahnen E, Androphy EJ, Wirth B. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci U S A 1999;96:6307-11.
7. Crawford TO, Pardo CA. The neurobiology of childhood spinal muscular atrophy. Neurobiol Dis 1996;3:97-110.
8. Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Violett L, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995;80:155-65.
9. Lorson CL, Androphy EJ. An exonic enhancer is required for inclusion of an essential exon in the SMA determining gene SMN. Hum Mol Genet 2000;9:259-65.
10. Cartegni L, Krainer AR. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet 2002;30:377-84.
11. Monani UR, Lorson CL, Parsons DW, Prior TW, Androphy EJ, Burghes AH, et al. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet 1999;8:1177-83.
12. Cartegni L, Hastings MI, Calarco JA, de Stanchina E, Krainer AR. Determinants of exon 7 splicing in the spinal muscular atrophy genes, SMN1 and SMN2. Am J Hum Genet 2006;78:63-77.
13. Mailman MD, Heinz JW, Papp AC, Snyder PJ, Sedra MS, Wirth B, et al. Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2. Genet Med 2002;4:20-6.
14. Swoboda KJ, Prior TW, Scott CB, McNaught TP, Wride MC, Reyna SP, et al. Natural history of denervation in SMA: relation to age, SMN2 copy number, and function. Ann Neurol 2005;57:704-12.
15. Carlson MD. Recent advances in newborn screening for neuro-metabolic disorders. Curr Opin Neurol 2004;17:133-8.
16. Wilcken B. Ethical issues in newborn screening and the impact of new technologies. Eur J Pediatr 2003;162:S62-6.
17. Green NS, Pass KA. Neonatal screening by DNA microarray: spots and chips. Nat Rev Genet 2005;6:147-51.
18. Saxena A. Issues in newborn screening. Genet Test 2003;7:131-4.
19. The Luminex Corporation. http://Luminexcorp.com (accessed April 2007).
20. Pyatt RE, Prior TW. A feasibility study for the newborn screening of spinal muscular atrophy. Genet Med 2006;8:428-37.
21. McAndrew PE, Parsons DW, Simard LR, Rochette C, Ray PN, Mendell JR, et al. Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet 1997;60:1411-22.
22. Bortolin S, Black M, Modi H, Boszko I, Kobler D, Fieldhouse D, et al. Analytical validation of the Tag-It high-throughput microsphere-based universal array genotyping platform: application to the multiplex detection of a panel of thrombophilia-associated single-nucleotide polymorphisms. Clin Chem 2004;50:2028-36.
23. Pietz BC, Warden MB, DuChateau BK, Ellis TM. Multiplex genotyping of human minor histocompatibility antigens. Hum Immunol 2005;66:1174-82.
24. Johnson SC, Marshall DJ, Harms G, Miller CM, Sherrill CB, Beaty EL, et al. Multiplexed genetic analysis using expanded genetic alphabet. Clin Chem 2004;50:2019-27.